However, further larger prospective studies that evaluated the benefit of serum MMP-7 in helping the physician to take decisions on diagnosis cholangiocarcinoma are necessary before the implementation of using serum MMP-7 as a marker for cholangiocarcinoma. This evidence concerns the gene MMP7 and cholangiocarcinoma.